HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obama Proposes Mostly Flat FY 2015 FDA Budget, Cosmetic User Fees

This article was originally published in The Rose Sheet

Executive Summary

The federal fiscal 2015 budget proposal would provide $4.74 billion to FDA, representing a 2% increase overall versus fiscal 2014; however, the figure includes user fees that would have be enacted, including $19 million from the cosmetics industry.

You may also be interested in...



Congressional Appropriators Urge FDA Action On Cosmetic Lead Limits

House and Senate committee reports on proposed FDA appropriations for fiscal 2015 direct the agency to respond to a nearly three-year-old petition requesting an agency-sanctioned limit on trace lead in lipstick and other cosmetics. Appropriators set a March 15, 2015 deadline for FDA’s response.

Sunscreen Bill Would Expedite TEA Decisions, Set Deadlines

The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.

Study Projecting Rise In Animal Tests Casts Pall On Safe Cosmetics Act

Results of a new study suggest that if enacted, the Safe Cosmetics and Personal Care Products Act would require a dramatic increase in animal testing in the United States. Bill sponsor Representative Jan Schakowsky told “The Rose Sheet” that she is “a vigorous opponent of animal testing” and does not want animal testing as an unanticipated consequence of the legislation.

Related Content

UsernamePublicRestriction

Register

LL1132247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel